Verona Pharma plc
Symbol: VRNA (NASDAQ)
106.19
▼ (-0.20%) -0.210
Company Description:
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Key Stats
- Today's Open: $106.3
- Today's High: $106.43
- Today's Low: $106.19
- Today's Volume: 918.70K
- Yesterday Close: $106.4
- Yesterday High: $106.4
- Yesterday Low: $106.3
- Yesterday Volume: 1.00M
- Last Min Volume: 1
- Last Min High: $106.19
- Last Min Low: $106.19
- Last Min VWAP: $106.19
Company Profile
- Name: Verona Pharma plc
- Website: https://www.veronapharma.com
- Listed Date: 2017-04-27
- Location: LONDON, X0
- Market Status: Active
- CIK Number: 0001657312
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.21B
- Round Lot: 100
- Outstanding Shares: 86.50M
- Asset Type: ADRC
RECENT FILINGS FOR VRNA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | DFAN14A | View |
| 2025-09-10 | DEFA14A | View |
| 2025-09-09 | 8-K | View |
| 2025-09-09 | DEFA14A | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-08-18 | DEFM14A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |